These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6786318)

  • 1. Inhibition of lipase production in Propionibacterium acnes by sub-minimal-inhibitory concentrations of tetracycline and erythromycin.
    Webster GF; McGinley KJ; Leyden JJ
    Br J Dermatol; 1981 Apr; 104(4):453-7. PubMed ID: 6786318
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of clindamycin, erythromycin, lincomycin, and tetracycline on growth and extracellular lipase production by propionibacteria in vitro.
    Unkles SE; Gemmell CG
    Antimicrob Agents Chemother; 1982 Jan; 21(1):39-43. PubMed ID: 7081974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antibiotics on the lipases of Corynebacterium acnes in vitro.
    Puhvel SM; Reisner RM
    Arch Dermatol; 1972 Jul; 106(1):45-9. PubMed ID: 4625030
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of lipase activity in antibiotic-resistant propionibacterium acnes strains.
    Gloor M; Wasik B; Becker A; Höffler U
    Dermatology; 2002; 205(3):260-4. PubMed ID: 12399674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil chemotaxis by Propionibacterium acnes lipase and its inhibition.
    Lee WL; Shalita AR; Suntharalingam K; Fikrig SM
    Infect Immun; 1982 Jan; 35(1):71-8. PubMed ID: 7054130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of subminimal inhibitory concentrations of erythromycin, tetracycline, clindamycin, and minocycline on the neutrophil chemotactic factor production in Propionibacterium acnes biotypes 1-5.
    Akamatsu H; Nishijima S; Takahashi M; Ushijima T; Asada Y
    J Dermatol; 1991 May; 18(5):247-51. PubMed ID: 1834712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory effects of erythromycin and tetracycline on Propionibacterium acnes induced production of chemotactic factors and reactive oxygen species by human neutrophils.
    Jain A; Sangal L; Basal E; Kaushal GP; Agarwal SK
    Dermatol Online J; 2002 Oct; 8(2):2. PubMed ID: 12546757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of polymorphonuclear leukocyte chemotactic factor production in Propionibacterium acnes by subminimal inhibitory concentrations of tetracycline, ampicillin, minocycline, and erythromycin.
    Webster GF; Leyden JJ; McGinley KJ; McArthur WP
    Antimicrob Agents Chemother; 1982 May; 21(5):770-2. PubMed ID: 7049078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of tetracyclines and erythromycin on complement activation in vitro.
    Ingham E
    Acta Derm Venereol; 1990; 70(6):531-4. PubMed ID: 1981435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of kaempferol isolated from the Impatiens balsamina alone and in combination with erythromycin or clindamycin against Propionibacterium acnes.
    Lim YH; Kim IH; Seo JJ
    J Microbiol; 2007 Oct; 45(5):473-7. PubMed ID: 17978809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of neutrophil chemotactic factor production in comedonal bacteria by subminimal inhibitory concentrations of erythromycin.
    Akamatsu H; Kurokawa I; Nishijima S; Asada Y
    Dermatology; 1992; 185(1):41-3. PubMed ID: 1386264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance of propionibacteria to antibiotics used in the treatment of acne.
    Brown JM; Poston SM
    J Med Microbiol; 1983 Aug; 16(3):271-80. PubMed ID: 6224016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility and genetic characteristics of Propionibacterium acnes isolated from patients with acne.
    Schafer F; Fich F; Lam M; Gárate C; Wozniak A; Garcia P
    Int J Dermatol; 2013 Apr; 52(4):418-25. PubMed ID: 23432195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of zinc and erythromycin on the growth of erythromycin-resistant and erythromycin-sensitive isolates of Propionibacterium acnes: an in-vitro study.
    Holland KT; Bojar RA; Cunliffe WJ; Cutcliffe AG; Eady EA; Farooq L; Farrell AM; Gribbon EM; Taylor D
    Br J Dermatol; 1992 May; 126(5):505-9. PubMed ID: 1610692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined photodynamic and antibiotic therapy for skin disorder via lipase-sensitive liposomes with enhanced antimicrobial performance.
    Jeong S; Lee J; Im BN; Park H; Na K
    Biomaterials; 2017 Oct; 141():243-250. PubMed ID: 28697465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Propionibacterium acnes lipase by extracts of Indian medicinal plants.
    Patil V; Bandivadekar A; Debjani D
    Int J Cosmet Sci; 2012 Jun; 34(3):234-9. PubMed ID: 22268921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Propionibacterium acnes lipase activity by the antifungal agent ketoconazole.
    Unno M; Cho O; Sugita T
    Microbiol Immunol; 2017 Jan; 61(1):42-44. PubMed ID: 28111792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of lipase activities of Propionibacterium granulosum and Propionibacterium acnes.
    Higaki S; Nakamura M; Kitagawa T; Morohashi M; Yamagishi T
    Drugs Exp Clin Res; 2001; 27(5-6):161-4. PubMed ID: 11951573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Roxithromycin on the production of lipase and neutrophil chemotactic factor by Propionibacterium acnes.
    Akamatsu H; Tomita T; Horio T
    Dermatology; 2002; 204(4):277-80. PubMed ID: 12077521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic sensitivity of comedonal Propionibacterium acnes.
    Guin JD; Huber DS; Gielerak PL
    Acta Derm Venereol; 1979; 59(6):552-54. PubMed ID: 94223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.